Insight

Radioligand Therapy Offers Hope to Lung Cancer Patients – Oncogene Cancer Research

Photo taken from nature.com

Sep 22, 2024, 18:11

Radioligand Therapy Offers Hope to Lung Cancer Patients – Oncogene Cancer Research

Oncogene Cancer Research posted the following on LinkedIn:

“Radioligand Therapy is offering hope to cancer patients through targeted nuclear medicine.

Here our Co-founder and two fellow patient advocates participate in a virtual demo showcasing how this therapy kills tumour cells. Quite a therapeutic and cathartic demo for lung cancer patients!

We hope this and other great innovations will bring real benefits to our lung cancer patient community. It’s why we’re focused on more research.”

Radioligand Therapy

Source: Oncogene Cancer Research/LinkedIn

#cancer patients cancer care cancer treatment Lung cancer OncoDaily Oncogene Cancer Research Oncology Patient Advocacy radioligand therapy Research targeted nuclear medicine therapeutic innovation

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage